# CG Oncology, Inc. (CGON) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from CG Oncology, Inc.'s 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/CGON/mda/fy2025/): filed 2026-02-27; accession 0001193125-26-079498 (https://www.sec.gov/Archives/edgar/data/1991792/000119312526079498/ck0001991792-20251231.htm); latest 10-K
- [FY 2024 MD&A](/company/CGON/mda/fy2024/): filed 2025-03-28; accession 0000950170-25-046351 (https://www.sec.gov/Archives/edgar/data/1991792/000095017025046351/ck0001991792-20241231.htm)
- [FY 2023 MD&A](/company/CGON/mda/fy2023/): filed 2024-03-26; accession 0000950170-24-036143 (https://www.sec.gov/Archives/edgar/data/1991792/000095017024036143/cgon_10k_2023_1231.htm)

Back to /company/CGON/